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Abstract
Background Synthetic hydroxyapatite (HA), beta-trical-
cium phosphate (b-TCP) and their composite are promising
biomaterials, specifically in the orthopedic and dental
fields, as their chemical composition is similar to that of
bone. Due to the need for safer bone graft applications,
these bone graft substitutes are gradually gaining increased
acceptability. To stimulate the process of bone healing,
several methods have been used previously, including
ultrasound, electrical stimulation, exposure to electromag-
netic fields, bone grafts, interporous hydroxyapatite (as a
bone graft substitute) and bone growth factors. The fol-
lowing study was designed to evaluate the effects of the
concurrent usage of hydroxyapatite with demineralized calf
fetal growth plate (DCFGP) on the bone healing process.
Materials and methods Fifteen female New Zealand
white rabbits were used in this study. A mid-radius bone
defect was created and in the first group (n = 5) was filled
with hydroxyapatite, in the second group (n = 5) with
hydroxyapatite and DCFGP, and finally in the third group
(n = 5) with DCFGP alone. Radiological and histopa-
thological evaluations were performed blindly and the
results scored and analyzed statistically.
Results There was a significant difference for bone for-
mation and remodeling at the 8th post-operative week
radiographic assessment (P\ 0.05), when the hydroxyap-
atite–DCFGP group was superior to other groups. On the
contrary, macroscopical and histopathological evaluation
did not revealed significant differences between the three
groups
Conclusion Given the contrasting results of the radio-
graphic assessment and the macro-/microscopic analysis of
the healing response, further studies are needed before
considering DCFGP-HA as a feasible alternative to
HA alone, especially considering the potential hazards and
costs of animal-derived biomaterials.
Level of evidence Not applicable.
Keywords Hydroxyapatite  Demineralized calf fetal
growth plate  Bone healing  Rabbit
Introduction
There is a continuing search for bone substitutes to avoid or
minimize the need for autogenous bone grafts. The use of
bone grafts in the management of nonunion cases is well
accepted. These grafts act as scaffolds which provide the
necessary biomechanical strength that is required to with-
stand the compressive forces involved during motion. They
also promote the ingrowth of cells and other biological
products, which eventually leads to the replacement of
these grafts by bioactive tissues [1]. Autografts are most
widely used by surgeons. These grafts contain viable cells
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such as bone marrow osteoprogenitor cells, a collagenous
matrix and noncollagenous extracellular growth and dif-
ferentiating factors. Consequently, the autograft is the pre-
eminent therapy for bone repair, because it is capable of
osteogenesis, osteoinduction and osteoconduction. How-
ever, a number of disadvantages such as morbidity in the
donor site, the need for general anesthesia or sedation, and
the occasional need for more than one surgical field have
previously been described in the application of autografts.
In addition, graft survival is unpredictable, its resorption
cannot be foretold and its availability is limited [2, 3]. It is
for these reasons that in recent years several biocompatible
materials have emerged as substitutes for autologous bone.
Biocompatible materials can be classified into two major
organic and synthetic groups. Biological biomaterials can
be allogeneic or homologous (human cortical bone and
demineralized bone matrix or demineralized freeze-dried),
heterologous or xenogeneic (organic bovine, porcine,
caprine or coral-derived hydroxyapatite) and replicating
(bone morphogenetic proteins; BMPs) [4]. Of the synthetic
biomaterial applications of artificial or synthetic hydroxy-
apatite, bioglasses and bioceramics are more common in
orthopedic surgery [5].
Recently, BMPs have been used in clinical trials to
enhance bone healing properties [6–8]. It has been stated
that BMPs are able to stimulate local undifferentiated
mesenchymal cells to transform into osteoblasts (osteoin-
duction), and lead to early bone formation [9–12]. More
study is still necessary to identify which BMPs have higher
osteoinductive properties and are more efficient in clinical
application. Based on the recent literature, it seems that
bone tissue engineering is the newest option for promoting
and accelerating the healing potential of bone defects [13].
In bone tissue engineering, it is possible to combine syn-
thetic scaffolds with biological biomaterials to stimulate
cell infiltration and new bone formation and to enhance the
healing process. In this regard, gene therapy (transfer of
genes that code growth factors such as BMPs to target cells
with the help of a plasmid or viral vector) may provide
promising results, although concerns over trans-infection
of the target cells with the gene are an unresolved issue
[14–17].
Stem cells such as adipose-derived stem cells (ASCs)
can differentiate into the osteogenic lineage. Furthermore,
osteoid matrix formation has been observed when osteo-
induced human ASCs were seeded onto hydroxyapatite/
tricalcium phosphate scaffolds and implanted subcutane-
ously in nude mice [18]. Cowan et al. [19] demonstrated
that osteo-induced ASCs along with the apatite-coated
polylactic-coglycolic acid scaffold could repair a critical-
sized calvarial defect of a mouse model. Meanwhile, Dudas
et al. [20] showed that ASCs in combination with gelatin
gel could repair a non-critical-sized defect in a rabbit
model with a follow-up of 6 weeks. All these results
indicate that ASCs could be an alternative cell source for
bone engineering [21].
Hydroxyapatite, a crystalline phase of calcium phos-
phate found naturally in bone minerals, has shown tre-
mendous promise as a graft material. It exhibits initial
mechanical rigidity and structure, and demonstrates os-
teoconductive as well as angiogenic properties in vivo [22].
Additionally, fabricated porous hydroxyapatite scaffolds
have been reported to promote a strong mechanical inter-
lock with the host bone tissue [22, 23]. Since the extent of
bony ingrowth within the scaffold, the functionality of
newly regenerated bone tissue, and the development of a
vascularized network within the scaffold are dictated by the
porous scaffold architecture, extensive studies have been
performed to optimize new biomaterials needed for maxi-
mal bone tissue integration [24, 25].
The presence of transforming growth factor b (TGF-b)
in growth plate [26] and BMPs 2 and 7 in human and rat
fetal growth plate have been identified previously [27].
These proteins promote the chondroblastic differentiation
of mesenchymal cells, followed by new bone synthesis by
endochondral osteogenesis [28, 29]. A previous study
proved that segmental bovine growth plate grafting has
potential osteoinductive properties [30]. More recently,
another study showed ectopic osteoinductive properties of
calf fetal growth plate in a rat sub-muscular model [31] and
bone healing enhancement in a rabbit bone defect model
[32]. The present study was designed to evaluate the bone
healing properties of demineralized calf fetal growth plate
concurrent with hydroxyapatite in a critical-sized bone
defect experimental rabbit model.
Materials and methods
Fifteen New Zealand white rabbits (12 months old, mixed
sex, weighing 2.0 ± 0.5 kg) were kept in separate cages,
fed a standard diet and allowed to move freely during the
study. The animals were randomly divided into three equal
groups: DCFGP group (n = 5), hydroxyapatite–DCFGP
group (n = 5) and hydroxyapatite group (n = 5 group). All
the animals were anesthetized by intramuscular adminis-
tration of 40 mg/kg ketamine hydrochloride and 5 mg/kg
xylazine. The right forelimb of all animals was prepared
aseptically for operation. A 5-cm incision was made cra-
niomedially in the skin of the forelimb and the radius was
exposed by dissecting the surrounding muscles. An oste-
operiosteal segmental defect was then created on the
middle portion of each radius at least twice as long as the
diameter of the diaphysis, for creation of a nonunion model
[33]. As the diameter of the radius of the adult New Zea-
land albino rabbit is about 5–6 mm, the radial defect was
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10–12 mm long. Therefore, an approximately 10-mm
segmental defect was created in the middle portion of each
radius as a critical-sized bone defect. The defect in the
animals in the hydroxyapatite group was filled with 1 mg
of hydroxyapatite segments (OS Satura, Isotis Co, Neth-
erlands). In the hydroxyapatite–DCFGP group the bone
defect was filled with 0.5 mg of hydroxyapatite segments
and 0.5 mg of DCFGP powder, while the defects in the
animals in the DCFGP group were filled with 1 mg of
DCFGP powder. The animals were housed in compliance
with our institution’s guiding principles ‘‘on the care and
use of animals’’. The local Ethics Committee for animal
experiments approved the design of the experiment.
A 6-month old bovine fetus was collected from the local
slaughter house. Metacarpal bones were dissected asepti-
cally from the fetal calf (Holstein) and all soft tissues were
removed. Radiographs were taken to determine the growth
plate’s margins and limitations. With an oscillating osteo-
tome, proximal and distal growth plates were cut and
retrieved under aseptic conditions. The retrieved growth
plate was then sliced. The demineralization process was
performed as described by Reddi and Huggins [34]. The
harvested growth plates were cleaned of soft tissue and
marrow, washed in sterile distilled water with continuous
stirring, then washed three times in 95 % ethanol for
15 min, rinsed in ether for 15 min, and finally air-dried
overnight. The cleaned and dried growth plates were milled
(Universal Mill A-20; Tekmer Co, Cincinnati, OH, USA)
to obtain 400–700-lm granules and then demineralized in
0.6-N HCl three times for 1 h (50 ml HCl per g of bone).
The growth plate powder was rinsed with several changes
of sterile distilled water to adjust the pH, three times in
95 % ethanol and once in ether. The growth plate powder
was air-dried and stored in sterile plastic containers at 4 C
until being used for implantation. This entire process was
performed under sterile conditions (except for the milling)
and a sample was cultured to demonstrate that specimens
contained no bacterial or fungal contamination.
To evaluate bone formation, union and remodeling of
the defect, radiographs of each forelimb were taken post-
operatively at the 2nd, 4th, 6th and 8th weeks post-injury.
The results were scored using the modified Lane and
Sandhu scoring system [35] (Table 1).
Animals were killed, and radius bones were explanted
on the 56th postoperative day for gross and histopatholo-
gical signs of healing. In gross evaluation, examination and
blinded scoring of the specimens included presence of
bridging bone, indicating a complete union (?3 score),
presence of cartilage, soft tissue or cracks within the defect
indicating a possible unstable union (?1 or ?2 score), or
complete instability at the defect site indicating no union (0
score).
For histopathological evaluation, sagital sections con-
taining the defect were cut with a slow-speed saw from the
harvested and dissected bones. Each slice was then fixed in
10 % neutral buffered formalin. The formalin-fixed bone
samples were decalcified in 15 % buffered formic acid
solution and processed for routine histological examina-
tion. Two sections 5 lm in thickness were cut from the
centers of each specimen and were stained with hematox-
ylin and eosin. The sections were blindly evaluated and
scored by two pathologists according to Emery’s scoring
system [36] and based on this scoring system the defects
were evaluated as follows: if the gap was empty
(score = 0), if the gap was filled with fibrous connective
tissue only (score = 1), with more fibrous tissue than
fibrocartilage (score = 2), more fibrocartilage than fibrous
tissue (score = 3), fibrocartilage only (score = 4), more
fibrocartilage than bone (score = 5), more bone than
fibrocartilage (score = 6) and filled only with bone
(score = 7).
Results
There was no intra-operative or postoperative death during
the study. None of the rabbits sustained an ulna bone
fracture at the radius bone defect.
At the 2nd, 4th and 6th postoperative weeks, the
radiographs did not show any significant differences
between any of the groups, whereas at the 8th postoperative
week the radiographs showed significant differences
Table 1 Modified Lane and Sandhu radiological scoring system
Bone formation
No evidence of bone formation 0
Bone formation occupying 25 % of the defect 1
Bone formation occupying 50 % of the defect 2
Bone formation occupying 75 % of the defect 3
Bone formation occupying 100 % of the defect 4





No evidence of remodeling 0
Remodeling of medullary canal 1
Full remodeling of cortex 2
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between the groups (p\ 0.05) (Figs. 1, 2, 3, 4; Table 2).
The hydroxyapatite–DCFGP group was significantly
(p\ 0.05) superior to the hydroxyapatite and DCFGP
groups. There were no significant differences between the
DCFGP and hydroxyapatite groups on any postoperative
day (Figs. 1, 2, 3, 4; Table 2).
The defect areas of the rabbits in all groups showed
various amounts of new bone formation; the union scores
of the rabbits in the hydroxyapatite–DCFGP group were
not statistically superior to those of the animals in the
hydroxyapatite and DCFGP groups (Table 3).
At the histopathological level, the defects in the animals
in the hydroxyapatite–DCFGP and hydroxyapatite and
DCFGP groups did not show significant differences on
statistical analysis (p[ 0.05) (Table 3).
The defects in all rabbits in the three groups were filled
with mature cortical bone (Fig. 5). Normal trabecular and
woven bone were uniformly formed within the defects and
the regenerated bone completely spanned the defect and
mostly produced full histological union (Fig. 5). No sig-
nificant inflammatory response was evident in the lesions
in the animals of different groups at 8 weeks post injury,
although it may have been present earlier.
Discussion
To evaluate the bone healing potential of a combination of
hydroxyapatite and DCFGP, a defect model was estab-
lished in the radius bone of rabbits. This model has
Fig. 1 Radiographs at 2nd week: A1 hydroxyapatite group, A2
hydroxyapatite–DCFGP group and A3 DCFGP group
Fig. 2 Radiographs at 4th week, B1 hydroxyapatite group, B2
hydroxyapatite–DCFGP group and B3 DCFGP group
Fig. 3 Radiographs at 6th week, C1 hydroxyapatite group, C2
hydroxyapatite–DCFGP group and C3 DCFGP group
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previously been reported suitable because there is no need
for internal or external fixation which influences the heal-
ing process [37]. Chaubey et al., in a murine model,
showed that bone defect healing occurred at 2 weeks and
were completely healed by 5 weeks, with biomechanical
properties not significantly different from normal controls.
However, critical-sized defects showed no healing by his-
tology or micro-computed tomography. These nonunion
fractures also displayed no torsional stiffness or strength in
10 out of 12 cases [38]. In the present study the segmental
defect was created in the middle portion of the radius, as
long as 10 mm, for inducing a nonunion defect and to
prevent spontaneous and rapid healing [33]. The hypothesis
was on the basis that the addition of DCFGP to a mixture of
particulate hydroxyapatite in a critical-sized defect in the
radius bone of rabbit could have a positive effect on bone
formation.
The results of the radiological examinations showed that
bone healing was enhanced when DCFGP was used con-
currently with hydroxapatite. Recently, a study indicated
that satisfactory ectopic bone formation occurred in a
submuscular rat model with xenogenic demineralized
bovine fetal growth plate, and complications were not
identified [31]. In addition, in two previous studies seg-
mental calf fetal growth plate was grafted in the radial bone
defect and a positive bone healing process was observed by
investigators [30, 39]. A more recent study showed
favorable bone defect healing with DCFGP in a rabbit
model [32]. In our study too, the DCFGP group showed
good bone healing the same as other groups on
Fig. 4 Radiographs at 8th week, D1 hydroxyapatite group, D2
hydroxyapatite–DCFGP group and D3 DCFGP group
Table 2 Radiographical findings for healing of the bone defect (sum of the radiological scores) at various post-operative intervals
Postoperative weeks Median (min–max) Pa
Hydroxyapatite group (n = 5) Hydroxyapatite–DCFGP group (n = 5) DCFGP group (n = 5)
2 1 (0–3) 3 (1–4) 1 (0–3) 0.08
4 4 (3–8) 7 (4–10) 5 (3–6) 0.1
6 5 (2–8) 8 (6–10) 5 (4–7) 0.07
8 6 (4–9) 9 (8–10)b 5 (4–7) 0.01
Significant P values are shown in bold face
a Kruskal–Wallis non-parametric analysis of variance
b Compared with hydroxyapatite group (p = 0.02) and DCFGP group (p = 0.008) by Mann–Whitney U test. Hydroxyapatite–DCFGP group
was significantly (p\ 0.05) superior to hydroxyapatite and DCFGP groups














3 (2–2) 3 (2–3) 2 (2–2) 0.1
Microscopic
evaluationb
6 (4–7) 7 (5–7) 5 (4–7) 0.1
a Complete union (?3 score), presence of cartilage, soft tissue or
cracks within the defect indicating a possible unstable union (? 1 or
?2 score), complete instability at the defect site indicating nonunion
(0 score)
b Empty (0 score), fibrous tissue only (1 score), more fibrous tissue
than fibrocartilage (2 score), more fibrocartilage than fibrous tissue (3
score), fibrocartilage only (4 score), more fibrocartilage than bone (5
score), more bone than fibrocartilage (6 score) and bone only (7 score)
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histopathological evaluation. The presence of TGF-b in the
growth plate [26] and BMPs 2 and 7 in human and rat fetal
growth plate [27] has been identified. These proteins pro-
mote the chondroblastic differentiation of mesenchymal
cells, followed by new bone synthesis by endochondral
osteogenesis [29]. The primary osteoinductive component
of demineralized bone matrix (DBM) is a series of low-
molecular-weight glycoproteins that includes the BMPs.
The decalcification of cortical bone exposes these osteo-
inductive growth factors buried within the mineralized
matrix, thereby enhancing the bone formation process.
These proteins promote the chondroblastic differentiation
of mesenchymal cells, followed by new bone synthesis by
endochondral osteogenesis [29, 40]. We propose that in our
study calf fetal growth plate demineralization led to the
exposure of TGF-b and BMPs 2 and 7 in the injured site,
and therefore the bone healing process in the DCFGP
group was superior to the control group. In the present
study DCFGP did not elicit any inflammatory reaction in
the grafted site in the DCFGP and hydroxyapatite–DCFGP
groups. It has been reported that the demineralization
process destroys the antigenic materials in bone, so that the
DBM becomes less immunogenic and does not induce an
immunological reaction by the host [41]; we did not
observe any inflammatory reaction throughout the histo-
pathological evaluation.
Hydroxyapatite, a crystalline phase of calcium phos-
phate found naturally in bone minerals, has shown tre-
mendous promise as a graft material. It exhibits initial
mechanical rigidity and structure, and demonstrates os-
teoconductive as well as angiogenic properties in vivo [22,
42, 43]. In osteoperiosteal gaps bridged with hydroxyapa-
tite only, the porosities were invaded with fibrous tissue or
fibrocartilage tissues more than bone tissues. Occasionally,
bone formation was observed in direct contact with
hydroxyapatite, confirming its osteoconductive ability, but
it was insufficient to allow union. These findings are sim-
ilar to those reported using hydroxyapatite [25]. When the
gap reaches a critical size, the osteoconductive properties
of the material are insufficient to fill the gap with formation
of new bone [44]. This model therefore proved to be ade-
quate for evaluating hydroxyapatite as a scaffold for
DCFGP. More unexpected is the formation of the cortex
and medullary canal together with mature lamellar bone
observed in most of the cases. The previous in vitro studies
have shown that artificial bone graft materials support the
attachment, growth and differentiation of the bone-marrow
stromal cells [45].
The rate of BMP release relies on its molecular weight,
its conformation and its solubility [46]. Gene therapy-based
strategies have also been introduced to improve BMP
delivery and their effectiveness at the target site [47]. This
technology provides the gene for the protein and results in
a higher and more constant level of BMPs for a sustained
time period [48]. To include the gene for BMPs into the
target cell, a delivery vehicle or vector is needed, viral or
non-viral [47].
Sohier et al. [49] investigated the efficiency of BMP-2
delivered by macroporous beta-tricalcium phosphate (b-
TCP) scaffolds. The scaffolds, loaded with 15 and 30 lg of
BMP-2, were implanted into the femoral defects and the
back muscles of rabbits, respectively. Bone was formed
within the BMP-2-loaded scaffold pores, both in the back
muscles and bone defects, independent of the implant site
effect. The results of that study indicated the efficacy and
suitability of b-TCP scaffolds as BMP-2 carriers for bone
regeneration. In another study, the in vitro and in vivo
effectiveness of an absorbable collagen sponge (ACS) with
72 lg rhBMP-2 (BMPC) and fibrin matrix with 10 lg
rhBMP-2 (BMPF) were compared with the ACS alone,
fibrin alone, and empty groups. BMP-2 release was signifi-
cantly higher in the BMPF group than in the BMPC group.
The bone union of femoral defects and the bone volume
were higher in the BMPC and BMPF groups than in other
groups. Interestingly, fibrin matrix even with a seven-fold
lower concentration of BMP-2 provided equivalent results
to collagen sponge. According to those results, it seems that
fibrin matrix could be an excellent carrier for BMP-2 [50].
Fig. 5 Micrographs of the injured bones after 8 weeks. Regenerated bone with typical structure of trabecular bone is seen in the defect in the
hydroxyapatite group (a, 910), hydroxyapatite–DCFGP group (b, 910) and DCFGP group (c, 910) (hematoxylin and eosin staining)
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Jun et al. [51] fabricated a silica xerogel–chitosan hybrid
for incorporating BMP-2 onto a porous hydroxyapatite
(HA) scaffold. They evaluated the biological properties of
the hybrid coating incorporated with BMP-2, in terms of the
release behavior of BMP-2, and also its in vivo performance
on calvarial defects in rabbits. The BMP-2-loaded hybrids
significantly enhanced new bone formation in comparison
to the pure porous HA scaffolds without BMP-2. Indeed, the
incorporation of BMP-2 into the hybrid promoted the os-
teoinductive properties of the HA scaffold. They introduced
the silica xerogel–chitosan hybrid as a promising candidate
for improving osteogenic properties of the HA scaffold with
the constant and prolonged release of BMP-2.
The findings of the present study suggest that
hydroxyapatite is a suitable resorbable carrier for DCFGP
in vivo. It serves as a substrate to promote attachment and
growth of the stem cells of the bone marrow, and as a
template to guide bone morphogenesis in a clinically rel-
evant volume. According to this phenomenon, in our study
the hydroxyapatite–DCFGP group showed good enhance-
ment of bone healing in comparison with hydroxyapatite
and DCGP on radiological evaluation at the 8th postoper-
ative week. Alper and colleagues [52] designed a study to
identify the role of HA and DBM combination in fracture
healing. After creating 5-mm segmental defects in the radii
of the rats, defects were grafted using DBM, HA and DBM/
HA mixture. After eight weeks of fracture healing, the radii
were investigated histologically, and the HA group was
found to have worse results when compared to the control
group. They stated that DBM alone was an osteogenetic
material for healing in non-union models of the rats, but
that using HA in conjunction caused these effects to fade
away. Moore and colleagues grafted wide ulnar defects of
dogs with HA/TCP mixtures. They used a half-and-half
mixture of autogenous cancellous bone and HA/TCP
mixtures for one of the other groups, and pure autogenous
cancellous bone for the control group. After six months, all
groups were evaluated radiologically, mechanically and
histhologically, and it was found that six dogs which were
only grafted with the HA/TCP mixture showed fibrous
nonunion, whereas other groups displayed union. As a
result, they suggested that HA/TCP should be used as a
mixture with autogenous grafts [53].
Hopp and colleagues [54] found similar results. They
designed an experiment in which the ulnar defects of rats
were grafted by HA, DBM, HA/DBM, autogenous bone
graft and allogenic bone graft in five different groups. At
the 6th week, they found that the plain HA group scored
worse than the control group, whereas all other groups
displayed better scores.
In our study, macroscopic and histopathological evalu-
ation did not reveal any significant differences between the
three groups after 8 weeks and showed favorable bone
healing scores in the three groups. The authors proposed
that there might be some differences during the earlier
stages of the healing but by 8 weeks post-injury the three
groups had reached almost the same level. As a result,
similar macroscopic and microscopic healing responses
were observed and further studies are needed before con-
sidering DCFGP-HA as an alternative to HA alone in
clinical practice, especially considering the potential bio-
logical risks of animal-derived materials.
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